E1210

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
02420112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Based on the structures of the reported compounds G884 [N-(3-(pentan-2-yloxy)phenyl)nicotinamide], E1210 [3-(3-(4-((pyridin-2… (More)
Is this relevant?
2015
2015
The in vitro and in vivo activity of the inositol acyltransferase inhibitor E1210 was evaluated against echinocandin-resistant… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Continued research toward the development of new antifungals that act via inhibition of glycosylphosphatidylinositol (GPI… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 5
  • figure 3
Is this relevant?
2012
2012
Fusarium (n = 67) and Scedosporium (n = 63) clinical isolates were tested by two reference broth microdilution (BMD) methods… (More)
Is this relevant?
Review
2012
Review
2012
  • Nir Osherov
  • Annals of the New York Academy of Sciences
  • 2012
Over 450 peer-reviewed papers containing the keyword Aspergillus fumigatus were published in 2011. Although this method may be an… (More)
  • figure 1
  • figure 2
Is this relevant?
2011
2011
E1210 is a new antifungal compound with a novel mechanism of action and broad spectrum of antifungal activity. We investigated… (More)
Is this relevant?
2011
2011
E1210 is a first-in-class, broad-spectrum antifungal with a novel mechanism of action-inhibition of fungal… (More)
Is this relevant?
2011
2011
E1210 is a first-in-class broad-spectrum antifungal that suppresses hyphal growth by inhibiting fungal glycophosphatidylinositol… (More)
Is this relevant?
2011
2011
The in vitro activity of the novel antifungal agent E1210 and four comparators (caspofungin, fluconazole, posaconazole, and… (More)
Is this relevant?
2011
2011
OBJECTIVES To compare European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI broth microdilution (BMD… (More)
  • table 1
  • table 2
Is this relevant?